This week, our exploration into psychedelics continues with Brooke Balliett, the cofounder and clinical director of the California Center for Psychedelic Therapy. Brooke helped us better understand the research-based medical side of psychedelics, and how ketamine, MDMA and psilocybin are being used to treat severe depression, PTSD, OCD and bipolar depression.

For more information on the California Center for Psychedelic Therapy, visit psychedelictherapyca.com.